nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Parkinson's disease—Diphenhydramine—atopic dermatitis	0.424	1	CpDpCtD
Hyoscyamine—Benzatropine—Dimenhydrinate—atopic dermatitis	0.133	0.455	CrCrCtD
Hyoscyamine—CHRM2—Dimenhydrinate—atopic dermatitis	0.118	0.672	CbGbCtD
Hyoscyamine—Cyclopentolate—Diphenhydramine—atopic dermatitis	0.0964	0.329	CrCrCtD
Hyoscyamine—Benzatropine—Diphenhydramine—atopic dermatitis	0.0633	0.216	CrCrCtD
Hyoscyamine—CHRM2—Diphenhydramine—atopic dermatitis	0.0575	0.328	CbGbCtD
Hyoscyamine—Arrhythmia—Prednisolone—atopic dermatitis	7.85e-05	0.000757	CcSEcCtD
Hyoscyamine—Vomiting—Mometasone—atopic dermatitis	7.8e-05	0.000753	CcSEcCtD
Hyoscyamine—Urticaria—Tacrolimus—atopic dermatitis	7.76e-05	0.000749	CcSEcCtD
Hyoscyamine—Rash—Mometasone—atopic dermatitis	7.74e-05	0.000747	CcSEcCtD
Hyoscyamine—Dermatitis—Mometasone—atopic dermatitis	7.73e-05	0.000746	CcSEcCtD
Hyoscyamine—Body temperature increased—Tacrolimus—atopic dermatitis	7.72e-05	0.000745	CcSEcCtD
Hyoscyamine—Abdominal pain—Tacrolimus—atopic dermatitis	7.72e-05	0.000745	CcSEcCtD
Hyoscyamine—Headache—Mometasone—atopic dermatitis	7.69e-05	0.000742	CcSEcCtD
Hyoscyamine—Arrhythmia—Hydrocortisone—atopic dermatitis	7.66e-05	0.000739	CcSEcCtD
Hyoscyamine—Erythema—Prednisolone—atopic dermatitis	7.64e-05	0.000738	CcSEcCtD
Hyoscyamine—Nausea—Fluocinolone Acetonide—atopic dermatitis	7.63e-05	0.000737	CcSEcCtD
Hyoscyamine—Mental disorder—Hydrocortisone—atopic dermatitis	7.51e-05	0.000725	CcSEcCtD
Hyoscyamine—Erythema—Hydrocortisone—atopic dermatitis	7.47e-05	0.00072	CcSEcCtD
Hyoscyamine—Bradycardia—Dexamethasone—atopic dermatitis	7.46e-05	0.00072	CcSEcCtD
Hyoscyamine—Bradycardia—Betamethasone—atopic dermatitis	7.46e-05	0.00072	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Prednisone—atopic dermatitis	7.34e-05	0.000708	CcSEcCtD
Hyoscyamine—Hallucination—Betamethasone—atopic dermatitis	7.29e-05	0.000703	CcSEcCtD
Hyoscyamine—Hallucination—Dexamethasone—atopic dermatitis	7.29e-05	0.000703	CcSEcCtD
Hyoscyamine—Nausea—Mometasone—atopic dermatitis	7.29e-05	0.000703	CcSEcCtD
Hyoscyamine—Arrhythmia—Triamcinolone—atopic dermatitis	7.21e-05	0.000696	CcSEcCtD
Hyoscyamine—Vision blurred—Prednisolone—atopic dermatitis	7.2e-05	0.000695	CcSEcCtD
Hyoscyamine—Arrhythmia—Methylprednisolone—atopic dermatitis	7.2e-05	0.000694	CcSEcCtD
Hyoscyamine—Hypersensitivity—Tacrolimus—atopic dermatitis	7.2e-05	0.000694	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Prednisone—atopic dermatitis	7.19e-05	0.000694	CcSEcCtD
Hyoscyamine—Depression—Prednisone—atopic dermatitis	7.09e-05	0.000684	CcSEcCtD
Hyoscyamine—Mental disorder—Methylprednisolone—atopic dermatitis	7.06e-05	0.000681	CcSEcCtD
Hyoscyamine—Erythema—Triamcinolone—atopic dermatitis	7.03e-05	0.000678	CcSEcCtD
Hyoscyamine—Erythema—Methylprednisolone—atopic dermatitis	7.01e-05	0.000677	CcSEcCtD
Hyoscyamine—Asthenia—Tacrolimus—atopic dermatitis	7.01e-05	0.000676	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Prednisone—atopic dermatitis	7.01e-05	0.000676	CcSEcCtD
Hyoscyamine—Angioedema—Prednisolone—atopic dermatitis	6.99e-05	0.000674	CcSEcCtD
Hyoscyamine—Myocardial infarction—Prednisone—atopic dermatitis	6.97e-05	0.000672	CcSEcCtD
Hyoscyamine—Pruritus—Tacrolimus—atopic dermatitis	6.91e-05	0.000667	CcSEcCtD
Hyoscyamine—Dysgeusia—Triamcinolone—atopic dermatitis	6.88e-05	0.000664	CcSEcCtD
Hyoscyamine—Vertigo—Prednisolone—atopic dermatitis	6.87e-05	0.000663	CcSEcCtD
Hyoscyamine—Syncope—Prednisolone—atopic dermatitis	6.86e-05	0.000661	CcSEcCtD
Hyoscyamine—Angioedema—Hydrocortisone—atopic dermatitis	6.82e-05	0.000658	CcSEcCtD
Hyoscyamine—Loss of consciousness—Prednisolone—atopic dermatitis	6.72e-05	0.000648	CcSEcCtD
Hyoscyamine—Vertigo—Hydrocortisone—atopic dermatitis	6.71e-05	0.000647	CcSEcCtD
Hyoscyamine—Syncope—Hydrocortisone—atopic dermatitis	6.7e-05	0.000646	CcSEcCtD
Hyoscyamine—Diarrhoea—Tacrolimus—atopic dermatitis	6.68e-05	0.000645	CcSEcCtD
Hyoscyamine—Convulsion—Prednisolone—atopic dermatitis	6.62e-05	0.000639	CcSEcCtD
Hyoscyamine—Loss of consciousness—Hydrocortisone—atopic dermatitis	6.56e-05	0.000633	CcSEcCtD
Hyoscyamine—Arrhythmia—Betamethasone—atopic dermatitis	6.55e-05	0.000632	CcSEcCtD
Hyoscyamine—Arrhythmia—Dexamethasone—atopic dermatitis	6.55e-05	0.000632	CcSEcCtD
Hyoscyamine—Bradycardia—Prednisone—atopic dermatitis	6.5e-05	0.000627	CcSEcCtD
Hyoscyamine—Convulsion—Hydrocortisone—atopic dermatitis	6.47e-05	0.000624	CcSEcCtD
Hyoscyamine—Dizziness—Tacrolimus—atopic dermatitis	6.46e-05	0.000623	CcSEcCtD
Hyoscyamine—Angioedema—Triamcinolone—atopic dermatitis	6.42e-05	0.00062	CcSEcCtD
Hyoscyamine—Angioedema—Methylprednisolone—atopic dermatitis	6.41e-05	0.000618	CcSEcCtD
Hyoscyamine—Erythema—Betamethasone—atopic dermatitis	6.38e-05	0.000615	CcSEcCtD
Hyoscyamine—Erythema—Dexamethasone—atopic dermatitis	6.38e-05	0.000615	CcSEcCtD
Hyoscyamine—Hallucination—Prednisone—atopic dermatitis	6.35e-05	0.000613	CcSEcCtD
Hyoscyamine—Anxiety—Hydrocortisone—atopic dermatitis	6.33e-05	0.000611	CcSEcCtD
Hyoscyamine—Vertigo—Triamcinolone—atopic dermatitis	6.32e-05	0.000609	CcSEcCtD
Hyoscyamine—Syncope—Triamcinolone—atopic dermatitis	6.3e-05	0.000608	CcSEcCtD
Hyoscyamine—Vertigo—Methylprednisolone—atopic dermatitis	6.3e-05	0.000608	CcSEcCtD
Hyoscyamine—Syncope—Methylprednisolone—atopic dermatitis	6.29e-05	0.000607	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Prednisolone—atopic dermatitis	6.24e-05	0.000602	CcSEcCtD
Hyoscyamine—Oedema—Prednisolone—atopic dermatitis	6.24e-05	0.000602	CcSEcCtD
Hyoscyamine—Vomiting—Tacrolimus—atopic dermatitis	6.21e-05	0.000599	CcSEcCtD
Hyoscyamine—Loss of consciousness—Triamcinolone—atopic dermatitis	6.18e-05	0.000596	CcSEcCtD
Hyoscyamine—Loss of consciousness—Methylprednisolone—atopic dermatitis	6.17e-05	0.000595	CcSEcCtD
Hyoscyamine—Rash—Tacrolimus—atopic dermatitis	6.16e-05	0.000594	CcSEcCtD
Hyoscyamine—Dermatitis—Tacrolimus—atopic dermatitis	6.15e-05	0.000594	CcSEcCtD
Hyoscyamine—Shock—Prednisolone—atopic dermatitis	6.14e-05	0.000592	CcSEcCtD
Hyoscyamine—Headache—Tacrolimus—atopic dermatitis	6.12e-05	0.00059	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	6.09e-05	0.000588	CcSEcCtD
Hyoscyamine—Oedema—Hydrocortisone—atopic dermatitis	6.09e-05	0.000588	CcSEcCtD
Hyoscyamine—Convulsion—Triamcinolone—atopic dermatitis	6.09e-05	0.000588	CcSEcCtD
Hyoscyamine—Tachycardia—Prednisolone—atopic dermatitis	6.09e-05	0.000587	CcSEcCtD
Hyoscyamine—Convulsion—Methylprednisolone—atopic dermatitis	6.08e-05	0.000586	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Prednisolone—atopic dermatitis	6.03e-05	0.000582	CcSEcCtD
Hyoscyamine—Shock—Hydrocortisone—atopic dermatitis	5.99e-05	0.000578	CcSEcCtD
Hyoscyamine—Anxiety—Methylprednisolone—atopic dermatitis	5.95e-05	0.000574	CcSEcCtD
Hyoscyamine—Tachycardia—Hydrocortisone—atopic dermatitis	5.95e-05	0.000574	CcSEcCtD
Hyoscyamine—Flushing—Prednisone—atopic dermatitis	5.92e-05	0.000571	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	5.89e-05	0.000568	CcSEcCtD
Hyoscyamine—Dry mouth—Triamcinolone—atopic dermatitis	5.85e-05	0.000565	CcSEcCtD
Hyoscyamine—Angioedema—Dexamethasone—atopic dermatitis	5.83e-05	0.000562	CcSEcCtD
Hyoscyamine—Angioedema—Betamethasone—atopic dermatitis	5.83e-05	0.000562	CcSEcCtD
Hyoscyamine—Nausea—Tacrolimus—atopic dermatitis	5.8e-05	0.00056	CcSEcCtD
Hyoscyamine—Confusional state—Methylprednisolone—atopic dermatitis	5.77e-05	0.000557	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Triamcinolone—atopic dermatitis	5.74e-05	0.000554	CcSEcCtD
Hyoscyamine—Oedema—Triamcinolone—atopic dermatitis	5.74e-05	0.000554	CcSEcCtD
Hyoscyamine—Vertigo—Dexamethasone—atopic dermatitis	5.73e-05	0.000553	CcSEcCtD
Hyoscyamine—Vertigo—Betamethasone—atopic dermatitis	5.73e-05	0.000553	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	5.72e-05	0.000552	CcSEcCtD
Hyoscyamine—Syncope—Betamethasone—atopic dermatitis	5.72e-05	0.000552	CcSEcCtD
Hyoscyamine—Syncope—Dexamethasone—atopic dermatitis	5.72e-05	0.000552	CcSEcCtD
Hyoscyamine—Arrhythmia—Prednisone—atopic dermatitis	5.7e-05	0.00055	CcSEcCtD
Hyoscyamine—Hypotension—Hydrocortisone—atopic dermatitis	5.69e-05	0.000549	CcSEcCtD
Hyoscyamine—Shock—Triamcinolone—atopic dermatitis	5.64e-05	0.000545	CcSEcCtD
Hyoscyamine—Insomnia—Prednisolone—atopic dermatitis	5.64e-05	0.000544	CcSEcCtD
Hyoscyamine—Shock—Methylprednisolone—atopic dermatitis	5.63e-05	0.000543	CcSEcCtD
Hyoscyamine—Loss of consciousness—Betamethasone—atopic dermatitis	5.61e-05	0.000541	CcSEcCtD
Hyoscyamine—Loss of consciousness—Dexamethasone—atopic dermatitis	5.61e-05	0.000541	CcSEcCtD
Hyoscyamine—Tachycardia—Triamcinolone—atopic dermatitis	5.6e-05	0.00054	CcSEcCtD
Hyoscyamine—Mental disorder—Prednisone—atopic dermatitis	5.59e-05	0.000539	CcSEcCtD
Hyoscyamine—Tachycardia—Methylprednisolone—atopic dermatitis	5.59e-05	0.000539	CcSEcCtD
Hyoscyamine—Erythema—Prednisone—atopic dermatitis	5.56e-05	0.000536	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Triamcinolone—atopic dermatitis	5.55e-05	0.000535	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	5.53e-05	0.000534	CcSEcCtD
Hyoscyamine—Convulsion—Betamethasone—atopic dermatitis	5.53e-05	0.000533	CcSEcCtD
Hyoscyamine—Convulsion—Dexamethasone—atopic dermatitis	5.53e-05	0.000533	CcSEcCtD
Hyoscyamine—Insomnia—Hydrocortisone—atopic dermatitis	5.51e-05	0.000532	CcSEcCtD
Hyoscyamine—Anxiety—Dexamethasone—atopic dermatitis	5.41e-05	0.000522	CcSEcCtD
Hyoscyamine—Anxiety—Betamethasone—atopic dermatitis	5.41e-05	0.000522	CcSEcCtD
Hyoscyamine—Dyspepsia—Hydrocortisone—atopic dermatitis	5.36e-05	0.000517	CcSEcCtD
Hyoscyamine—Hypotension—Methylprednisolone—atopic dermatitis	5.35e-05	0.000516	CcSEcCtD
Hyoscyamine—Pain—Prednisolone—atopic dermatitis	5.34e-05	0.000515	CcSEcCtD
Hyoscyamine—Fatigue—Hydrocortisone—atopic dermatitis	5.25e-05	0.000507	CcSEcCtD
Hyoscyamine—Vision blurred—Prednisone—atopic dermatitis	5.24e-05	0.000505	CcSEcCtD
Hyoscyamine—Pain—Hydrocortisone—atopic dermatitis	5.21e-05	0.000503	CcSEcCtD
Hyoscyamine—Oedema—Dexamethasone—atopic dermatitis	5.21e-05	0.000502	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Betamethasone—atopic dermatitis	5.21e-05	0.000502	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Dexamethasone—atopic dermatitis	5.21e-05	0.000502	CcSEcCtD
Hyoscyamine—Oedema—Betamethasone—atopic dermatitis	5.21e-05	0.000502	CcSEcCtD
Hyoscyamine—Insomnia—Triamcinolone—atopic dermatitis	5.19e-05	0.000501	CcSEcCtD
Hyoscyamine—Insomnia—Methylprednisolone—atopic dermatitis	5.18e-05	0.0005	CcSEcCtD
Hyoscyamine—Feeling abnormal—Prednisolone—atopic dermatitis	5.14e-05	0.000496	CcSEcCtD
Hyoscyamine—Shock—Betamethasone—atopic dermatitis	5.12e-05	0.000494	CcSEcCtD
Hyoscyamine—Shock—Dexamethasone—atopic dermatitis	5.12e-05	0.000494	CcSEcCtD
Hyoscyamine—Dyspnoea—Triamcinolone—atopic dermatitis	5.12e-05	0.000493	CcSEcCtD
Hyoscyamine—Agitation—Prednisone—atopic dermatitis	5.1e-05	0.000493	CcSEcCtD
Hyoscyamine—Tachycardia—Dexamethasone—atopic dermatitis	5.08e-05	0.00049	CcSEcCtD
Hyoscyamine—Tachycardia—Betamethasone—atopic dermatitis	5.08e-05	0.00049	CcSEcCtD
Hyoscyamine—Angioedema—Prednisone—atopic dermatitis	5.08e-05	0.00049	CcSEcCtD
Hyoscyamine—Dyspepsia—Triamcinolone—atopic dermatitis	5.05e-05	0.000487	CcSEcCtD
Hyoscyamine—Dyspepsia—Methylprednisolone—atopic dermatitis	5.04e-05	0.000486	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Dexamethasone—atopic dermatitis	5.03e-05	0.000486	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Betamethasone—atopic dermatitis	5.03e-05	0.000486	CcSEcCtD
Hyoscyamine—Feeling abnormal—Hydrocortisone—atopic dermatitis	5.02e-05	0.000484	CcSEcCtD
Hyoscyamine—Vertigo—Prednisone—atopic dermatitis	4.99e-05	0.000482	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	4.98e-05	0.000481	CcSEcCtD
Hyoscyamine—Syncope—Prednisone—atopic dermatitis	4.98e-05	0.000481	CcSEcCtD
Hyoscyamine—Urticaria—Prednisolone—atopic dermatitis	4.96e-05	0.000478	CcSEcCtD
Hyoscyamine—Fatigue—Triamcinolone—atopic dermatitis	4.95e-05	0.000477	CcSEcCtD
Hyoscyamine—Fatigue—Methylprednisolone—atopic dermatitis	4.94e-05	0.000476	CcSEcCtD
Hyoscyamine—Pain—Triamcinolone—atopic dermatitis	4.91e-05	0.000473	CcSEcCtD
Hyoscyamine—Loss of consciousness—Prednisone—atopic dermatitis	4.88e-05	0.000471	CcSEcCtD
Hyoscyamine—Hypotension—Betamethasone—atopic dermatitis	4.86e-05	0.000469	CcSEcCtD
Hyoscyamine—Hypotension—Dexamethasone—atopic dermatitis	4.86e-05	0.000469	CcSEcCtD
Hyoscyamine—Urticaria—Hydrocortisone—atopic dermatitis	4.84e-05	0.000467	CcSEcCtD
Hyoscyamine—Abdominal pain—Hydrocortisone—atopic dermatitis	4.82e-05	0.000465	CcSEcCtD
Hyoscyamine—Body temperature increased—Hydrocortisone—atopic dermatitis	4.82e-05	0.000465	CcSEcCtD
Hyoscyamine—Convulsion—Prednisone—atopic dermatitis	4.81e-05	0.000464	CcSEcCtD
Hyoscyamine—Feeling abnormal—Triamcinolone—atopic dermatitis	4.73e-05	0.000456	CcSEcCtD
Hyoscyamine—Feeling abnormal—Methylprednisolone—atopic dermatitis	4.72e-05	0.000455	CcSEcCtD
Hyoscyamine—Anxiety—Prednisone—atopic dermatitis	4.71e-05	0.000455	CcSEcCtD
Hyoscyamine—Insomnia—Betamethasone—atopic dermatitis	4.71e-05	0.000454	CcSEcCtD
Hyoscyamine—Insomnia—Dexamethasone—atopic dermatitis	4.71e-05	0.000454	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	4.68e-05	0.000452	CcSEcCtD
Hyoscyamine—Hypersensitivity—Prednisolone—atopic dermatitis	4.6e-05	0.000443	CcSEcCtD
Hyoscyamine—Dyspepsia—Dexamethasone—atopic dermatitis	4.58e-05	0.000442	CcSEcCtD
Hyoscyamine—Dyspepsia—Betamethasone—atopic dermatitis	4.58e-05	0.000442	CcSEcCtD
Hyoscyamine—Urticaria—Triamcinolone—atopic dermatitis	4.56e-05	0.00044	CcSEcCtD
Hyoscyamine—Urticaria—Methylprednisolone—atopic dermatitis	4.55e-05	0.000439	CcSEcCtD
Hyoscyamine—Body temperature increased—Triamcinolone—atopic dermatitis	4.54e-05	0.000438	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Prednisone—atopic dermatitis	4.53e-05	0.000437	CcSEcCtD
Hyoscyamine—Oedema—Prednisone—atopic dermatitis	4.53e-05	0.000437	CcSEcCtD
Hyoscyamine—Abdominal pain—Methylprednisolone—atopic dermatitis	4.53e-05	0.000437	CcSEcCtD
Hyoscyamine—Hypersensitivity—Hydrocortisone—atopic dermatitis	4.49e-05	0.000433	CcSEcCtD
Hyoscyamine—Fatigue—Dexamethasone—atopic dermatitis	4.49e-05	0.000433	CcSEcCtD
Hyoscyamine—Fatigue—Betamethasone—atopic dermatitis	4.49e-05	0.000433	CcSEcCtD
Hyoscyamine—Shock—Prednisone—atopic dermatitis	4.46e-05	0.00043	CcSEcCtD
Hyoscyamine—Pain—Dexamethasone—atopic dermatitis	4.45e-05	0.000429	CcSEcCtD
Hyoscyamine—Pain—Betamethasone—atopic dermatitis	4.45e-05	0.000429	CcSEcCtD
Hyoscyamine—Tachycardia—Prednisone—atopic dermatitis	4.42e-05	0.000427	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Prednisone—atopic dermatitis	4.38e-05	0.000423	CcSEcCtD
Hyoscyamine—Asthenia—Hydrocortisone—atopic dermatitis	4.37e-05	0.000422	CcSEcCtD
Hyoscyamine—Pruritus—Hydrocortisone—atopic dermatitis	4.31e-05	0.000416	CcSEcCtD
Hyoscyamine—Feeling abnormal—Dexamethasone—atopic dermatitis	4.29e-05	0.000414	CcSEcCtD
Hyoscyamine—Feeling abnormal—Betamethasone—atopic dermatitis	4.29e-05	0.000414	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	4.26e-05	0.000411	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Betamethasone—atopic dermatitis	4.26e-05	0.000411	CcSEcCtD
Hyoscyamine—Hypersensitivity—Triamcinolone—atopic dermatitis	4.23e-05	0.000408	CcSEcCtD
Hyoscyamine—Hypersensitivity—Methylprednisolone—atopic dermatitis	4.22e-05	0.000407	CcSEcCtD
Hyoscyamine—Diarrhoea—Hydrocortisone—atopic dermatitis	4.17e-05	0.000402	CcSEcCtD
Hyoscyamine—Urticaria—Dexamethasone—atopic dermatitis	4.14e-05	0.000399	CcSEcCtD
Hyoscyamine—Urticaria—Betamethasone—atopic dermatitis	4.14e-05	0.000399	CcSEcCtD
Hyoscyamine—Dizziness—Prednisolone—atopic dermatitis	4.13e-05	0.000398	CcSEcCtD
Hyoscyamine—Asthenia—Triamcinolone—atopic dermatitis	4.12e-05	0.000397	CcSEcCtD
Hyoscyamine—Body temperature increased—Betamethasone—atopic dermatitis	4.12e-05	0.000397	CcSEcCtD
Hyoscyamine—Abdominal pain—Dexamethasone—atopic dermatitis	4.12e-05	0.000397	CcSEcCtD
Hyoscyamine—Body temperature increased—Dexamethasone—atopic dermatitis	4.12e-05	0.000397	CcSEcCtD
Hyoscyamine—Abdominal pain—Betamethasone—atopic dermatitis	4.12e-05	0.000397	CcSEcCtD
Hyoscyamine—Asthenia—Methylprednisolone—atopic dermatitis	4.11e-05	0.000396	CcSEcCtD
Hyoscyamine—Insomnia—Prednisone—atopic dermatitis	4.1e-05	0.000396	CcSEcCtD
Hyoscyamine—Pruritus—Triamcinolone—atopic dermatitis	4.06e-05	0.000392	CcSEcCtD
Hyoscyamine—Pruritus—Methylprednisolone—atopic dermatitis	4.05e-05	0.000391	CcSEcCtD
Hyoscyamine—Dizziness—Hydrocortisone—atopic dermatitis	4.03e-05	0.000389	CcSEcCtD
Hyoscyamine—Dyspepsia—Prednisone—atopic dermatitis	3.99e-05	0.000385	CcSEcCtD
Hyoscyamine—Rash—Prednisolone—atopic dermatitis	3.93e-05	0.00038	CcSEcCtD
Hyoscyamine—Dermatitis—Prednisolone—atopic dermatitis	3.93e-05	0.000379	CcSEcCtD
Hyoscyamine—Diarrhoea—Methylprednisolone—atopic dermatitis	3.92e-05	0.000378	CcSEcCtD
Hyoscyamine—Fatigue—Prednisone—atopic dermatitis	3.91e-05	0.000377	CcSEcCtD
Hyoscyamine—Headache—Prednisolone—atopic dermatitis	3.91e-05	0.000377	CcSEcCtD
Hyoscyamine—Constipation—Prednisone—atopic dermatitis	3.88e-05	0.000374	CcSEcCtD
Hyoscyamine—Vomiting—Hydrocortisone—atopic dermatitis	3.87e-05	0.000374	CcSEcCtD
Hyoscyamine—Rash—Hydrocortisone—atopic dermatitis	3.84e-05	0.000371	CcSEcCtD
Hyoscyamine—Dermatitis—Hydrocortisone—atopic dermatitis	3.84e-05	0.00037	CcSEcCtD
Hyoscyamine—Headache—Hydrocortisone—atopic dermatitis	3.82e-05	0.000368	CcSEcCtD
Hyoscyamine—Dizziness—Triamcinolone—atopic dermatitis	3.79e-05	0.000366	CcSEcCtD
Hyoscyamine—Dizziness—Methylprednisolone—atopic dermatitis	3.79e-05	0.000365	CcSEcCtD
Hyoscyamine—Feeling abnormal—Prednisone—atopic dermatitis	3.74e-05	0.00036	CcSEcCtD
Hyoscyamine—Asthenia—Betamethasone—atopic dermatitis	3.74e-05	0.00036	CcSEcCtD
Hyoscyamine—Asthenia—Dexamethasone—atopic dermatitis	3.74e-05	0.00036	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Prednisone—atopic dermatitis	3.71e-05	0.000358	CcSEcCtD
Hyoscyamine—Nausea—Prednisolone—atopic dermatitis	3.71e-05	0.000358	CcSEcCtD
Hyoscyamine—Pruritus—Dexamethasone—atopic dermatitis	3.68e-05	0.000355	CcSEcCtD
Hyoscyamine—Pruritus—Betamethasone—atopic dermatitis	3.68e-05	0.000355	CcSEcCtD
Hyoscyamine—Vomiting—Triamcinolone—atopic dermatitis	3.65e-05	0.000352	CcSEcCtD
Hyoscyamine—Vomiting—Methylprednisolone—atopic dermatitis	3.64e-05	0.000351	CcSEcCtD
Hyoscyamine—Nausea—Hydrocortisone—atopic dermatitis	3.62e-05	0.000349	CcSEcCtD
Hyoscyamine—Rash—Triamcinolone—atopic dermatitis	3.62e-05	0.000349	CcSEcCtD
Hyoscyamine—Dermatitis—Triamcinolone—atopic dermatitis	3.61e-05	0.000349	CcSEcCtD
Hyoscyamine—Rash—Methylprednisolone—atopic dermatitis	3.61e-05	0.000348	CcSEcCtD
Hyoscyamine—Dermatitis—Methylprednisolone—atopic dermatitis	3.61e-05	0.000348	CcSEcCtD
Hyoscyamine—Urticaria—Prednisone—atopic dermatitis	3.6e-05	0.000347	CcSEcCtD
Hyoscyamine—Headache—Triamcinolone—atopic dermatitis	3.59e-05	0.000347	CcSEcCtD
Hyoscyamine—Headache—Methylprednisolone—atopic dermatitis	3.59e-05	0.000346	CcSEcCtD
Hyoscyamine—Body temperature increased—Prednisone—atopic dermatitis	3.58e-05	0.000346	CcSEcCtD
Hyoscyamine—Abdominal pain—Prednisone—atopic dermatitis	3.58e-05	0.000346	CcSEcCtD
Hyoscyamine—Diarrhoea—Betamethasone—atopic dermatitis	3.56e-05	0.000344	CcSEcCtD
Hyoscyamine—Diarrhoea—Dexamethasone—atopic dermatitis	3.56e-05	0.000344	CcSEcCtD
Hyoscyamine—Dizziness—Dexamethasone—atopic dermatitis	3.44e-05	0.000332	CcSEcCtD
Hyoscyamine—Dizziness—Betamethasone—atopic dermatitis	3.44e-05	0.000332	CcSEcCtD
Hyoscyamine—Nausea—Triamcinolone—atopic dermatitis	3.41e-05	0.000329	CcSEcCtD
Hyoscyamine—Nausea—Methylprednisolone—atopic dermatitis	3.4e-05	0.000328	CcSEcCtD
Hyoscyamine—Hypersensitivity—Prednisone—atopic dermatitis	3.34e-05	0.000322	CcSEcCtD
Hyoscyamine—Vomiting—Dexamethasone—atopic dermatitis	3.31e-05	0.000319	CcSEcCtD
Hyoscyamine—Vomiting—Betamethasone—atopic dermatitis	3.31e-05	0.000319	CcSEcCtD
Hyoscyamine—Rash—Dexamethasone—atopic dermatitis	3.28e-05	0.000317	CcSEcCtD
Hyoscyamine—Rash—Betamethasone—atopic dermatitis	3.28e-05	0.000317	CcSEcCtD
Hyoscyamine—Dermatitis—Betamethasone—atopic dermatitis	3.28e-05	0.000316	CcSEcCtD
Hyoscyamine—Dermatitis—Dexamethasone—atopic dermatitis	3.28e-05	0.000316	CcSEcCtD
Hyoscyamine—Headache—Dexamethasone—atopic dermatitis	3.26e-05	0.000315	CcSEcCtD
Hyoscyamine—Headache—Betamethasone—atopic dermatitis	3.26e-05	0.000315	CcSEcCtD
Hyoscyamine—Asthenia—Prednisone—atopic dermatitis	3.25e-05	0.000314	CcSEcCtD
Hyoscyamine—Pruritus—Prednisone—atopic dermatitis	3.21e-05	0.000309	CcSEcCtD
Hyoscyamine—Diarrhoea—Prednisone—atopic dermatitis	3.1e-05	0.000299	CcSEcCtD
Hyoscyamine—Nausea—Betamethasone—atopic dermatitis	3.09e-05	0.000298	CcSEcCtD
Hyoscyamine—Nausea—Dexamethasone—atopic dermatitis	3.09e-05	0.000298	CcSEcCtD
Hyoscyamine—Dizziness—Prednisone—atopic dermatitis	3e-05	0.000289	CcSEcCtD
Hyoscyamine—Vomiting—Prednisone—atopic dermatitis	2.88e-05	0.000278	CcSEcCtD
Hyoscyamine—Rash—Prednisone—atopic dermatitis	2.86e-05	0.000276	CcSEcCtD
Hyoscyamine—Dermatitis—Prednisone—atopic dermatitis	2.86e-05	0.000276	CcSEcCtD
Hyoscyamine—Headache—Prednisone—atopic dermatitis	2.84e-05	0.000274	CcSEcCtD
Hyoscyamine—Nausea—Prednisone—atopic dermatitis	2.69e-05	0.00026	CcSEcCtD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	1.68e-05	0.00389	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.59e-05	0.00366	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CXCL10—atopic dermatitis	1.56e-05	0.0036	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CCR3—atopic dermatitis	1.49e-05	0.00343	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CCR3—atopic dermatitis	1.48e-05	0.00342	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—CCL5—atopic dermatitis	1.47e-05	0.0034	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CCR3—atopic dermatitis	1.47e-05	0.00339	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—PPARA—atopic dermatitis	1.46e-05	0.00338	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL22—atopic dermatitis	1.45e-05	0.00335	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL22—atopic dermatitis	1.45e-05	0.00334	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL22—atopic dermatitis	1.43e-05	0.00331	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CCL27—atopic dermatitis	1.43e-05	0.00329	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CCL27—atopic dermatitis	1.42e-05	0.00328	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CCL27—atopic dermatitis	1.41e-05	0.00325	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCL11—atopic dermatitis	1.39e-05	0.00321	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	1.38e-05	0.00319	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	1.37e-05	0.00317	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—FCER2—atopic dermatitis	1.37e-05	0.00316	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	1.36e-05	0.00314	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CCL5—atopic dermatitis	1.34e-05	0.0031	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—CCR5—atopic dermatitis	1.33e-05	0.00307	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—TAC1—atopic dermatitis	1.32e-05	0.00306	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—NPS—atopic dermatitis	1.32e-05	0.00306	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—NPS—atopic dermatitis	1.32e-05	0.00305	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—TAC1—atopic dermatitis	1.32e-05	0.00305	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—NPS—atopic dermatitis	1.31e-05	0.00302	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—TAC1—atopic dermatitis	1.31e-05	0.00302	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CXCR3—atopic dermatitis	1.3e-05	0.003	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CXCR3—atopic dermatitis	1.3e-05	0.00299	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL27—atopic dermatitis	1.29e-05	0.00299	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL27—atopic dermatitis	1.29e-05	0.00298	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CXCR3—atopic dermatitis	1.28e-05	0.00296	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL27—atopic dermatitis	1.28e-05	0.00295	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL22—atopic dermatitis	1.27e-05	0.00294	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	1.25e-05	0.00288	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CCR3—atopic dermatitis	1.25e-05	0.00288	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	1.24e-05	0.00287	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	1.23e-05	0.00285	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CCR5—atopic dermatitis	1.21e-05	0.00279	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.21e-05	0.00279	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.19e-05	0.00274	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.18e-05	0.00273	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.17e-05	0.00271	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL17—atopic dermatitis	1.16e-05	0.00268	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL17—atopic dermatitis	1.16e-05	0.00267	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL17—atopic dermatitis	1.15e-05	0.00265	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL27—atopic dermatitis	1.13e-05	0.00262	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCR3—atopic dermatitis	1.13e-05	0.00261	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	1.11e-05	0.00257	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—NPS—atopic dermatitis	1.11e-05	0.00256	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—TAC1—atopic dermatitis	1.11e-05	0.00256	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CXCR3—atopic dermatitis	1.09e-05	0.00251	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.07e-05	0.00247	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	1.07e-05	0.00247	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.07e-05	0.00246	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.06e-05	0.00244	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	1.05e-05	0.00243	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CXCL10—atopic dermatitis	1.05e-05	0.00242	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CXCL10—atopic dermatitis	1.04e-05	0.00239	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—IL5—atopic dermatitis	1.03e-05	0.00238	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL17—atopic dermatitis	1.02e-05	0.00235	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—NPS—atopic dermatitis	1.01e-05	0.00233	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—TAC1—atopic dermatitis	1.01e-05	0.00233	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CXCR3—atopic dermatitis	9.89e-06	0.00228	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	9.59e-06	0.00221	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL5—atopic dermatitis	9.38e-06	0.00217	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	9.36e-06	0.00216	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL11—atopic dermatitis	9.33e-06	0.00215	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL11—atopic dermatitis	9.24e-06	0.00213	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	9.23e-06	0.00213	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FCER2—atopic dermatitis	9.2e-06	0.00212	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FCER2—atopic dermatitis	9.11e-06	0.0021	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—KIF3A—atopic dermatitis	9.07e-06	0.00209	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	9.04e-06	0.00209	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CCL5—atopic dermatitis	9.01e-06	0.00208	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CCL5—atopic dermatitis	8.92e-06	0.00206	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CXCL10—atopic dermatitis	8.8e-06	0.00203	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GLB1—atopic dermatitis	8.7e-06	0.00201	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	8.58e-06	0.00198	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL22—atopic dermatitis	8.55e-06	0.00197	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL22—atopic dermatitis	8.47e-06	0.00196	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	8.4e-06	0.00194	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CCR3—atopic dermatitis	8.37e-06	0.00193	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ADSL—atopic dermatitis	8.34e-06	0.00193	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CCR3—atopic dermatitis	8.29e-06	0.00192	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL11—atopic dermatitis	8.2e-06	0.00189	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CMA1—atopic dermatitis	8.2e-06	0.00189	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	8.15e-06	0.00188	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CCR5—atopic dermatitis	8.12e-06	0.00187	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	8.11e-06	0.00187	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CCR5—atopic dermatitis	8.04e-06	0.00186	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—CXCL8—atopic dermatitis	8.03e-06	0.00185	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CXCL10—atopic dermatitis	7.99e-06	0.00185	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	7.76e-06	0.00179	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—STAT6—atopic dermatitis	7.71e-06	0.00178	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	7.65e-06	0.00177	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	7.63e-06	0.00176	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	7.62e-06	0.00176	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	7.6e-06	0.00176	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CCL5—atopic dermatitis	7.58e-06	0.00175	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	7.55e-06	0.00174	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	7.53e-06	0.00174	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	7.49e-06	0.00173	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	7.49e-06	0.00173	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	7.46e-06	0.00172	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	7.46e-06	0.00172	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	7.39e-06	0.00171	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	7.39e-06	0.00171	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	7.34e-06	0.0017	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	7.32e-06	0.00169	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—CXCL8—atopic dermatitis	7.3e-06	0.00169	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	7.25e-06	0.00167	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	6.96e-06	0.00161	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	6.94e-06	0.0016	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCL5—atopic dermatitis	6.88e-06	0.00159	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	6.87e-06	0.00159	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	6.86e-06	0.00158	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	6.84e-06	0.00158	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CCR5—atopic dermatitis	6.83e-06	0.00158	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	6.8e-06	0.00157	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	6.8e-06	0.00157	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	6.78e-06	0.00157	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	6.78e-06	0.00157	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	6.77e-06	0.00156	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	6.71e-06	0.00155	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	6.71e-06	0.00155	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCR3—atopic dermatitis	6.68e-06	0.00154	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	6.67e-06	0.00154	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	6.65e-06	0.00154	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	6.58e-06	0.00152	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.47e-06	0.00149	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.45e-06	0.00149	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.38e-06	0.00147	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	6.32e-06	0.00146	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	6.3e-06	0.00146	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	6.26e-06	0.00145	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	6.24e-06	0.00144	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CCR5—atopic dermatitis	6.2e-06	0.00143	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	6.11e-06	0.00141	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	6.09e-06	0.00141	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	6.03e-06	0.00139	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TAC1—atopic dermatitis	5.96e-06	0.00138	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NPS—atopic dermatitis	5.96e-06	0.00138	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	5.94e-06	0.00137	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	5.92e-06	0.00137	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	5.86e-06	0.00135	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCR3—atopic dermatitis	5.84e-06	0.00135	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL5—atopic dermatitis	5.54e-06	0.00128	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	5.53e-06	0.00128	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	5.53e-06	0.00128	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	5.51e-06	0.00127	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	5.51e-06	0.00127	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	5.46e-06	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	5.46e-06	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	5.39e-06	0.00124	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	5.37e-06	0.00124	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	5.32e-06	0.00123	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	5.2e-06	0.0012	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	5.18e-06	0.0012	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	5.18e-06	0.0012	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	5.13e-06	0.00118	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	5.11e-06	0.00118	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	5.09e-06	0.00118	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	5.04e-06	0.00116	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	4.92e-06	0.00114	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	4.91e-06	0.00113	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.91e-06	0.00113	CbGpPWpGaD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.89e-06	0.00113	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	4.86e-06	0.00112	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL10—atopic dermatitis	4.72e-06	0.00109	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	4.64e-06	0.00107	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	4.62e-06	0.00107	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	4.6e-06	0.00106	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	4.59e-06	0.00106	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	4.58e-06	0.00106	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	4.54e-06	0.00105	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	4.51e-06	0.00104	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	4.49e-06	0.00104	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	4.45e-06	0.00103	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	4.18e-06	0.000965	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	4.17e-06	0.000962	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	4.13e-06	0.000953	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	4.13e-06	0.000953	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	4.06e-06	0.000939	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	4.02e-06	0.000928	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NPS—atopic dermatitis	4.02e-06	0.000928	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NPS—atopic dermatitis	4e-06	0.000925	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	4e-06	0.000925	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	3.97e-06	0.000916	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NPS—atopic dermatitis	3.97e-06	0.000916	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	3.94e-06	0.000911	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	3.94e-06	0.00091	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	3.93e-06	0.000907	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	3.89e-06	0.000898	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NGF—atopic dermatitis	3.76e-06	0.000869	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	3.75e-06	0.000866	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL5—atopic dermatitis	3.73e-06	0.000862	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL5—atopic dermatitis	3.72e-06	0.00086	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL5—atopic dermatitis	3.69e-06	0.000851	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	3.66e-06	0.000846	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	3.58e-06	0.000827	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	3.18e-06	0.000735	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	3.17e-06	0.000733	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	3.14e-06	0.000726	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	3.1e-06	0.000717	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPARA—atopic dermatitis	2.82e-06	0.000652	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.78e-06	0.000643	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	2.77e-06	0.000641	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	2.75e-06	0.000634	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	2.74e-06	0.000633	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	2.73e-06	0.000631	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	2.71e-06	0.000625	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	2.66e-06	0.000614	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	2.65e-06	0.000612	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	2.63e-06	0.000606	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NGF—atopic dermatitis	2.54e-06	0.000586	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NGF—atopic dermatitis	2.53e-06	0.000584	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	2.53e-06	0.000584	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	2.52e-06	0.000582	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NGF—atopic dermatitis	2.51e-06	0.000579	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	2.49e-06	0.000576	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	2.47e-06	0.00057	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	2.46e-06	0.000568	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	2.44e-06	0.000563	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	2.42e-06	0.000558	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	2.41e-06	0.000556	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	2.38e-06	0.000551	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	2.21e-06	0.000511	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL2—atopic dermatitis	2.12e-06	0.000489	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	2.11e-06	0.000486	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	2.09e-06	0.000483	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	2.09e-06	0.000482	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	2.07e-06	0.000477	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	1.95e-06	0.00045	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	1.49e-06	0.000345	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	1.49e-06	0.000344	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	1.47e-06	0.00034	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL2—atopic dermatitis	1.43e-06	0.000329	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL2—atopic dermatitis	1.42e-06	0.000328	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	1.42e-06	0.000328	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	1.42e-06	0.000327	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL2—atopic dermatitis	1.41e-06	0.000325	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	1.4e-06	0.000324	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.31e-06	0.000303	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	1.31e-06	0.000302	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	1.3e-06	0.000299	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL6—atopic dermatitis	1.24e-06	0.000287	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL6—atopic dermatitis	8.39e-07	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL6—atopic dermatitis	8.36e-07	0.000193	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL6—atopic dermatitis	8.28e-07	0.000191	CbGpPWpGaD
